(VIANEWS) – Fortress Biotech (FBIOP), Brookfield Property Partners L.P. (BPYPN), MFS Charter Income Trust (MCR) have the highest dividend yield stocks on this list.
| Financial Asset | Forward Dividend Yield | Updated (EST) |
|---|---|---|
| Fortress Biotech (FBIOP) | 45.6% | 2024-10-12 11:14:05 |
| Brookfield Property Partners L.P. (BPYPN) | 9.58% | 2024-10-11 07:15:05 |
| MFS Charter Income Trust (MCR) | 8.49% | 2024-10-19 16:55:14 |
| Civista Bancshares (CIVB) | 3.66% | 2024-10-11 19:08:05 |
| EastGroup Properties (EGP) | 3.02% | 2024-10-18 05:06:06 |
| Chesapeake Energy Corporation (CHK) | 2.76% | 2024-10-17 15:08:05 |
Almost 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. Fortress Biotech (FBIOP) – Dividend Yield: 45.6%
Fortress Biotech’s last close was $5.14, 71.44% under its 52-week high of $18.00. Intraday change was 0.98%.
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin conditions; Luxamend for dressing and managing wounds; and Accutane capsules for severe recalcitrant nodular acne. It also develops late stage product candidates, such as intravenous Tramadol for the treatment of post-operative acute pain; CUTX-101, an injection for the treatment of Menkes disease; MB-107 and MB-207 for the treatment of X-linked severe combined immunodeficiency; Cosibelimab for metastatic cancers; CK-101 for the treatment of patients with EGFR mutation-positive NSCLC; CAEL-101 for the treatment of amyloid light chain amyloidosis; Triplex vaccine for cytomegalovirus; and CEVA101 for the treatment of severe traumatic brain injury in adults and children. The company's early stage product candidates include MB-102 for blastic plasmacytoid dendritic cell neoplasm; MB-101 for glioblastoma; MB-104 for multiple myeloma and light chain amyloidosis; MB-106 for B-cell non-hodgkin lymphoma; MB-103 for GBM & metastatic breast cancer to brain; MB-108; MB-105 for prostate and pancreatic cancers; and BAER-101. Its preclinical product candidates comprise AAV-ATP7A gene therapy; AVTS-001 gene therapy; CK-103 BET inhibitor; CEVA-D and CEVA-102; CK-302, an anti-GITR; CK-303, an anti-CAIX; ConVax; and ONCOlogues, and oligonucleotide platform. It has collaboration arrangements with universities, research institutes, and pharmaceutical companies. The company was formerly known as Coronado Biosciences, Inc. and changed its name to Fortress Biotech, Inc. in April 2015. Fortress Biotech, Inc. was incorporated in 2006 and is based in New York, New York.
Earnings Per Share
As for profitability, Fortress Biotech has a trailing twelve months EPS of $-0.86.
More news about Fortress Biotech.
2. Brookfield Property Partners L.P. (BPYPN) – Dividend Yield: 9.58%
Brookfield Property Partners L.P.’s last close was $15.01, 3.1% under its 52-week high of $15.49. Intraday change was -0.6%.
Brookfield Property Partners, through Brookfield Property Partners L.P. and its subsidiary Brookfield Property REIT Inc., is one of the world's premier real estate companies, with approximately $88 billion in total assets. We own and operate iconic properties in the world's major markets, and our global portfolio includes office, retail, multifamily, logistics, hospitality, triple net lease, manufactured housing and student housing. Brookfield Property Partners is the flagship listed real estate company of Brookfield Asset Management Inc., a leading global alternative asset manager with over $600 billion in assets under management. More information is available at www.brookfield.com.
Earnings Per Share
As for profitability, Brookfield Property Partners L.P. has a trailing twelve months EPS of $2.2.
PE Ratio
Brookfield Property Partners L.P. has a trailing twelve months price to earnings ratio of 6.84. Meaning, the purchaser of the share is investing $6.84 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.21%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Sep 3, 2024, the estimated forward annual dividend rate is 1.44 and the estimated forward annual dividend yield is 9.58%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 4.4%, now sitting on 10.71B for the twelve trailing months.
More news about Brookfield Property Partners L.P..
3. MFS Charter Income Trust (MCR) – Dividend Yield: 8.49%
MFS Charter Income Trust’s last close was $6.40, 4.48% under its 52-week high of $6.70. Intraday change was -0.16%.
MFS Charter Income Trust is a closed ended fixed income mutual fund launched and managed by Massachusetts Financial Services Company. The fund invests in the fixed income markets across the globe. It invests primarily in corporate bonds of U.S. or foreign issuers, U.S. Government securities, foreign government securities, mortgage-backed, and other asset-backed securities of U.S. or foreign issuers, or debt instruments of issuers located in emerging market countries. The fund employs a combination of fundamental and quantitative analysis with bottom-up stock picking approach to create its portfolio. It seeks to benchmarks the performance of its portfolio against a combination of the Barclays U.S. High-Yield Corporate Bond 2% Issuer Capped Index, MFS Charter Income Trust Blended Index, Barclays U.S. Credit Bond Index, Barclays U.S. Government/Mortgage Bond Index, Citigroup World Government Bond Non-Dollar Hedged Index, and JPMorgan Emerging Markets Bond Index Global. MFS Charter Income Trust was formed on July 20, 1989 and is domiciled in the United States.
Earnings Per Share
As for profitability, MFS Charter Income Trust has a trailing twelve months EPS of $0.54.
PE Ratio
MFS Charter Income Trust has a trailing twelve months price to earnings ratio of 11.85. Meaning, the purchaser of the share is investing $11.85 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.85%.
More news about MFS Charter Income Trust.
4. Civista Bancshares (CIVB) – Dividend Yield: 3.66%
Civista Bancshares ‘s last close was $17.75, 6.58% under its 52-week high of $19.00. Intraday change was 1.6%.
Civista Bancshares, Inc. operates as the financial holding company for Civista Bank that provides community banking services. It collects a range of customer deposits; and offers commercial and agriculture, commercial and residential real estate, farm real estate, real estate construction, consumer, and other loans, as well as letters of credit. The company also purchases equity securities; and provides trust and third-party insurance services. It operates in North Central, West Central, South Western Ohio, South Eastern Indiana, and Northern Kentucky. The company was formerly known as First Citizens Banc Corp and changed its name to Civista Bancshares, Inc. in May 2015. Civista Bancshares, Inc. was founded in 1884 and is headquartered in Sandusky, Ohio.
Earnings Per Share
As for profitability, Civista Bancshares has a trailing twelve months EPS of $2.13.
PE Ratio
Civista Bancshares has a trailing twelve months price to earnings ratio of 8.33. Meaning, the purchaser of the share is investing $8.33 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.25%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is a negative 33.3% and a negative 25.8%, respectively.
Yearly Top and Bottom Value
Civista Bancshares ‘s stock is valued at $17.75 at 10:15 EST, below its 52-week high of $19.00 and way above its 52-week low of $13.60.
Sales Growth
Civista Bancshares ‘s sales growth is negative 4.6% for the present quarter and 4.1% for the next.
Revenue Growth
Year-on-year quarterly revenue growth declined by 6.9%, now sitting on 147.54M for the twelve trailing months.
More news about Civista Bancshares .
5. EastGroup Properties (EGP) – Dividend Yield: 3.02%
EastGroup Properties’s last close was $182.02, 5.5% under its 52-week high of $192.61. Intraday change was -1.75%.
EastGroup Properties, Inc. (NYSE: EGP), an S&P MidCap 400 company, is a self-administered equity real estate investment trust focused on the development, acquisition and operation of industrial properties in major Sunbelt markets throughout the United States with an emphasis in the states of Florida, Texas, Arizona, California and North Carolina. The Company's goal is to maximize shareholder value by being a leading provider in its markets of functional, flexible and quality business distribution space for location sensitive customers (primarily in the 15,000 to 70,000 square foot range). The Company's strategy for growth is based on ownership of premier distribution facilities generally clustered near major transportation features in supply-constrained submarkets. EastGroup's portfolio, including development projects and value-add acquisitions in lease-up and under construction, currently includes approximately 45.7 million square feet.
Earnings Per Share
As for profitability, EastGroup Properties has a trailing twelve months EPS of $4.8.
PE Ratio
EastGroup Properties has a trailing twelve months price to earnings ratio of 37.92. Meaning, the purchaser of the share is investing $37.92 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.09%.
Yearly Top and Bottom Value
EastGroup Properties’s stock is valued at $182.02 at 10:15 EST, under its 52-week high of $192.61 and way higher than its 52-week low of $154.75.
More news about EastGroup Properties.
6. Chesapeake Energy Corporation (CHK) – Dividend Yield: 2.76%
Chesapeake Energy Corporation’s last close was $86.46, 7.61% under its 52-week high of $93.58. Intraday change was -0.96%.
Chesapeake Energy Corporation engages in the acquisition, exploration, and development of properties for the production of oil, natural gas, and natural gas liquids (NGL) from underground reservoirs in the United States. The company holds interests in natural gas resource plays, including the Marcellus in Northern Appalachian Basin in Pennsylvania; Haynesville located in Northwestern Louisiana; Eagle Ford in South Texas; Brazos Valley in Southeast Texas; and Powder River Basin in Wyoming. As of December 31, 2020, it owned interests in approximately 7,400 oil and natural gas wells, including 5,900 properties with working interest and 1,500 properties with royalty interest; and had estimated proved reserves of 60 Mmboe. The company was founded in 1989 and is headquartered in Oklahoma City, Oklahoma.
Earnings Per Share
As for profitability, Chesapeake Energy Corporation has a trailing twelve months EPS of $3.03.
PE Ratio
Chesapeake Energy Corporation has a trailing twelve months price to earnings ratio of 26.88. Meaning, the purchaser of the share is investing $26.88 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.22%.
More news about Chesapeake Energy Corporation.
